Olisaemeka Zikora Akunne

University of Nigeria

Also at Federal Capital Territory Administrationfrom their recent papers

Publishing since 2024, latest 2025

Immunology
Oncology
Public Health, Environmental and Occupational Health
Applied Microbiology and Biotechnology
Cardiology and Cardiovascular Medicine
Ecology

Publications: 62024–2025
Citations: 31to those papers
h-index: 3i10-index 2
Field-weighted impact: 1.851.00 is the world average
World top 10%: 33%2 of 6 scored papers
Open access: 100%6 papers free to read

1 other work — a preprint, a dataset or the like — is listed but not counted.

By year

Papers, and the citations to them

Publications, left axisCitations to that year’s papers, right axis2026 still in progress

Citations received each year

Peerford

To all their work, old papers included. Google Scholar also counts citations from theses, books and web pages, so its line runs higher.

What they work on

From the classification of each paper

Subfields

Immunology233%
Oncology233%

Career

On their papers

Every institution they have given on a paper.

Publications

6 in all

Antibiotic resistance: The growing threats and potential solutions
2025American Journal of Pharmacotherapy and Pharmaceutical SciencesJournalOpen accessFirst authorCorresponding3 citations10.25259/ajpps_2025_013
Innovative nanoparticle-based therapies for pancreatic neuroendocrine tumours (PNETs): advances, challenges, and future directions

Download CV:PDFWord

Public Health, Environmental and Occupational Health233%

Applied Microbiology and Biotechnology117%

Cardiology and Cardiovascular Medicine117%

Emergency Medical Services117%

Endocrinology, Diabetes and Metabolism117%

Health Sciences
Life Sciences
Physical Sciences
Social Sciences

Topics most written on

Antibiotic Use and Resistance1
Asthma and respiratory diseases1
Bacteriophages and microbial interactions1
Cancer Immunotherapy and Biomarkers1
Cardiovascular Function and Risk Factors1
Diabetes Treatment and Management1
Heart Failure Treatment and Management1
Immune Cell Function and Interaction1
Immune responses and vaccinations1
Immunotherapy and Immune Responses1
Lung Cancer Research Studies1
Malaria Research and Control1

Who they write with

Their most frequent co-authors, and the papers those co-authors share

Where their co-authors are

33% of their papers have a co-author abroad

papers co-written1111111Home

Most frequent partner countries

South Africa1
United States1

Papers with at least one author in that country.

Institutions written with most

Ahmadu Bello UniversityNG2 papers
Ambrose Alli UniversityNG2 papers
Enugu State University of Science and TechnologyNG2 papers
Federal Medical CentreNG2 papers
Federal Capital Territory AdministrationNG2 papers
Usmanu Danfodiyo UniversityNG2 papers
Federal Medical CentreNG2 papers
Old Dominion UniversityUS1 paper
Medical Laboratory Science Council of NigeriaNG1 paper
Nigerian Institute of Medical ResearchNG1 paper

Where they publish

American Journal of Pharmacotherapy and Pharmaceutical Sciences2
Clinical and Experimental Vaccine Research1
Discover Pharmaceutical Sciences1
International Journal of Molecular and Immuno Oncology1
PLoS ONE1

How it can be read

100% free to read

Diamond 1 · 17%Free to read and to publish
Gold 2 · 33%In an open-access journal
Hybrid 3 · 50%Open in a subscription journal

Development goals addressed

From each paper’s title and abstract

3Good health and well-being3
4Quality education1

Most cited

Evaluating the knowledge, attitude, perception, and readiness of caregivers of under 5-year-old children to accept malaria vaccine in Nigeria
Clinical and Experimental Vaccine Research3
202414 citationsWorld top 10%Open access · Diamond
Emerging strategies in cancer immunotherapy: Expanding horizons and future perspectives
International Journal of Molecular and Immuno Oncology3
202410 citationsOpen access · Hybrid
Antibiotic resistance: The growing threats and potential solutions
American Journal of Pharmacotherapy and Pharmaceutical Sciences
20253 citationsWorld top 10%Open access · Hybrid
Innovative nanoparticle-based therapies for pancreatic neuroendocrine tumours (PNETs): advances, challenges, and future directions
Discover Pharmaceutical Sciences
20252 citationsOpen access · Gold
Emerging therapies targeting cardiovascular risk factors to prevent or delay the onset of heart failure
American Journal of Pharmacotherapy and Pharmaceutical Sciences3
20242 citationsOpen access · Hybrid

Discover Pharmaceutical Sciences

Emerging strategies in cancer immunotherapy: Expanding horizons and future perspectives

2024International Journal of Molecular and Immuno OncologyJournalOpen accessFirst authorCorresponding10 citations10.25259/ijmio_24_2024

Emerging therapies targeting cardiovascular risk factors to prevent or delay the onset of heart failure

2024American Journal of Pharmacotherapy and Pharmaceutical SciencesJournalOpen accessFirst authorCorresponding2 citations10.25259/ajpps_2024_013